Table 3.
Adverse events | Grade 1 | Grade 2 | Grade 3 | Grade 4 |
---|---|---|---|---|
Anemia | 20 | 1 | 0 | 0 |
Leukocytosis | 1 | 1 | 1 | 0 |
Platelet count decreased | 1 | 0 | 1 | 0 |
Hyponatremia | 3 | 0 | 0 | 0 |
Hypernatremia | 2 | 0 | 0 | 0 |
Hyperkalemia | 4 | 1 | 0 | 0 |
AST/ALT increased | 8 | 0 | 2 | 0 |
Cr increased | 6 | 0 | 2 | 0 |
Hot flashes | 9 | 0 | 0 | 0 |
Constipation | 3 | 0 | 0 | 0 |
Malaise | 1 | 0 | 0 | 0 |
Penile pain | 1 | 0 | 0 | 0 |
Device related infection | 0 | 0 | 1 | 0 |
Upper respiratory infection | 0 | 1 | 0 | 0 |
Arthralgia | 1 | 0 | 0 | 0 |
Urinary frequency | 2 | 0 | 0 | 0 |
Depression | 1 | 0 | 0 | 0 |
Pruritus | 1 | 0 | 0 | 0 |
Gynecomastia | 1 | 0 | 0 | 0 |
Laryngopharyngeal dysesthesia | 1 | 0 | 0 | 0 |
Irregular menstruation | 1 | 0 | 0 | 0 |
Dizziness | 2 | 0 | 0 | 0 |
Dysgeusia | 1 | 0 | 0 | 0 |
Erythema multiforme | 1 | 0 | 0 | 0 |
AST/ALT, alanine transaminase/aspartate aminotransferase ratio; Cr, creatinine.